244 related articles for article (PubMed ID: 9356112)
1. Peripherally administered alpha2-adrenoceptor agonist in the modulation of chronic allodynia induced by spinal nerve ligation in the rat.
Wei H; Pertovaara A
Anesth Analg; 1997 Nov; 85(5):1122-7. PubMed ID: 9356112
[TBL] [Abstract][Full Text] [Related]
2. The effect of a selective alpha2-adrenoceptor antagonist on pain behavior of the rat varies, depending on experimental parameters.
Kauppila T; Jyväsjärvi E; Hämäläinen MM; Pertovaara A
Pharmacol Biochem Behav; 1998 Feb; 59(2):477-85. PubMed ID: 9476998
[TBL] [Abstract][Full Text] [Related]
3. The effects of the alpha2-adrenergic agonist, dexmedetomidine, in the spinal nerve ligation model of neuropathic pain in rats.
Kontinen VK; Paananen S; Kalso E
Anesth Analg; 1998 Feb; 86(2):355-60. PubMed ID: 9459248
[TBL] [Abstract][Full Text] [Related]
4. Different roles of alpha 2-adrenoceptors of the medulla versus the spinal cord in modulation of mustard oil-induced central hyperalgesia in rats.
Mansikka H; Idänpään-Heikkilä JJ; Pertovaara A
Eur J Pharmacol; 1996 Feb; 297(1-2):19-26. PubMed ID: 8851161
[TBL] [Abstract][Full Text] [Related]
5. The role of alpha 2-adrenoceptors of the medullary lateral reticular nucleus in spinal antinociception in rats.
Mansikka H; Pertovaara A
Brain Res Bull; 1995; 37(6):633-8. PubMed ID: 7670889
[TBL] [Abstract][Full Text] [Related]
6. The analgesic potency of dexmedetomidine is enhanced after nerve injury: a possible role for peripheral alpha2-adrenoceptors.
Poree LR; Guo TZ; Kingery WS; Maze M
Anesth Analg; 1998 Oct; 87(4):941-8. PubMed ID: 9768799
[TBL] [Abstract][Full Text] [Related]
7. Involvement of supraspinal and spinal segmental alpha-2-adrenergic mechanisms in the medetomidine-induced antinociception.
Pertovaara A; Kauppila T; Jyväsjärvi E; Kalso E
Neuroscience; 1991; 44(3):705-14. PubMed ID: 1684411
[TBL] [Abstract][Full Text] [Related]
8. The influence of chemical sympathectomy on pain responsivity and alpha 2-adrenergic antinociception in neuropathic animals.
Wei H; Jyväsjärvi E; Niissalo S; Hukkanen M; Waris E; Konttinen YT; Pertovaara A
Neuroscience; 2002; 114(3):655-68. PubMed ID: 12220567
[TBL] [Abstract][Full Text] [Related]
9. Spinal and pontine alpha2-adrenoceptors have opposite effects on pain-related behavior in the neuropathic rat.
Wei H; Pertovaara A
Eur J Pharmacol; 2006 Dec; 551(1-3):41-9. PubMed ID: 17027962
[TBL] [Abstract][Full Text] [Related]
10. The antinociceptive action of an alpha 2-adrenoceptor agonist in the spinal dorsal horn is due to a direct spinal action and not to activation of descending inhibition.
Hämäläinen MM; Pertovaara A
Brain Res Bull; 1995; 37(6):581-7. PubMed ID: 7670881
[TBL] [Abstract][Full Text] [Related]
11. Influence of selective alpha 2-adrenergic agents on mustard oil-induced central hyperalgesia in rats.
Mansikka H; Pertovaara A
Eur J Pharmacol; 1995 Jul; 281(1):43-8. PubMed ID: 8566115
[TBL] [Abstract][Full Text] [Related]
12. Pineal melatonin in rats: suppression by the selective alpha2-adrenoceptor agonist medetomidine.
Mustanoja SM; Hätönen T; Johansson-Alila A; Laakso ML
Eur J Pharmacol; 1997 May; 326(2-3):229-36. PubMed ID: 9196276
[TBL] [Abstract][Full Text] [Related]
13. Induction and suppression of immediate-early genes in the rat brain by a selective alpha-2-adrenoceptor agonist and antagonist following noxious peripheral stimulation.
Pertovaara A; Bravo R; Herdegen T
Neuroscience; 1993 May; 54(1):117-26. PubMed ID: 8100045
[TBL] [Abstract][Full Text] [Related]
14. The effect of medetomidine, an alpha 2-adrenoceptor agonist, in various pain tests.
Pertovaara A; Kauppila T; Tukeva T
Eur J Pharmacol; 1990 Apr; 179(3):323-8. PubMed ID: 1973106
[TBL] [Abstract][Full Text] [Related]
15. Effects of radolmidine, a novel alpha2 -adrenergic agonist compared with dexmedetomidine in different pain models in the rat.
Xu M; Kontinen VK; Kalso E
Anesthesiology; 2000 Aug; 93(2):473-81. PubMed ID: 10910498
[TBL] [Abstract][Full Text] [Related]
16. The role of alpha-2 adrenoceptor subtype in the antiallodynic effect of intraplantar dexmedetomidine in a rat spinal nerve ligation model.
Lee HG; Choi JI; Kim YO; Yoon MH
Neurosci Lett; 2013 Dec; 557 Pt B():118-22. PubMed ID: 24161890
[TBL] [Abstract][Full Text] [Related]
17. The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats.
Haapalinna A; Leino T; Heinonen E
Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):342-51. PubMed ID: 14566451
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of the alpha 2-adrenergic antinociception from sedation following microinjection of medetomidine into the locus coeruleus in rats.
Pertovaara A; Hämäläinen MM; Kauppila T; Mecke E; Carlson S
Pain; 1994 May; 57(2):207-215. PubMed ID: 7916451
[TBL] [Abstract][Full Text] [Related]
19. Evidence against alpha2-adrenoceptor involvement in the regulation of rat melatonin synthesis by ambient lighting.
Mustanoja SM; Hätönen T; Alila-Johansson A; Laakso ML
Neuroscience; 1999; 92(3):967-73. PubMed ID: 10426536
[TBL] [Abstract][Full Text] [Related]
20. Melatonin release from rat pineals in vitro is stimulated by both the alpha(2)-adrenoceptor agonist medetomidine and the antagonist atipamezole.
Mustanoja SM; Bäck N; Alila-Johansson A; Laakso ML
Eur J Pharmacol; 1999 Oct; 383(1):75-82. PubMed ID: 10556684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
